Interaction of circulating TGFβ regulatory miRNAs in different severity of diabetic kidney disease

References

• Agarwal, V., et al., 2015. Predicting effective microRNA target sites in mammalian mRNAs. eLife, 4. doi:10.7554/eLife.05005
   Web of Science ®Google Scholar
• American Diabetes Association, 2018. Diabetes advocacy. Diabetes care, 41 (Suppl 1), S152–S153.
   PubMedGoogle Scholar
• American Diabetes Association, 2019a. Classification and diagnosis of diabetes. Diabetes care, 42 (Suppl 1), S13–S28.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association, 2019b. Diabetes advocacy. Diabetes care, 42 (Suppl 1), S182–S183.
   PubMedGoogle Scholar
• Assmann, T.S., et al., 2018. MicroRNAs and diabetic kidney disease: systematic review and bioinformatic analysis. Molecular and cellular endocrinology, 477, 90–102.
   PubMed Web of Science ®Google Scholar
• Bacon, S., et al., 2015. MicroRNA-224 is readily detectable in urine of individuals with diabetes mellitus and is a potential indicator of beta-cell demise. Genes, 6 (2), 399–416.
   PubMed Web of Science ®Google Scholar
• Bartel, D.P., 2018. Metazoan microRNAs. Cell, 173 (1), 20–51.
   PubMed Web of Science ®Google Scholar
• Chalmers, J., 1999. The 1999 WHO-ISH guidelines for the management of hypertension. The medical journal of Australia, 171 (9), 458–459.
   PubMed Web of Science ®Google Scholar
• Chamberlain, J.J., et al., 2019. Diabetes technology: review of the 2019 American Diabetes Association standards of medical care in diabetes. Annals of internal medicine, 171 (6), 415–420.
   PubMed Web of Science ®Google Scholar
• Colhoun, H.M., and Marcovecchio, M.L., 2018. Biomarkers of diabetic kidney disease. Diabetologia, 61 (5), 996–1011.
   PubMed Web of Science ®Google Scholar
• Cui, J., and Shu, J., 2020. Circulating microRNA trafficking and regulation: computational principles and practice. Briefings in bioinformatics, 21 (4), 1313–1326.
   PubMed Web of Science ®Google Scholar
• Espinel, E., et al., 2015. Renal biopsy in type 2 diabetic patients. Journal of clinical medicine, 4 (5), 998–1009.
   PubMed Web of Science ®Google Scholar
• Fan, P.-C., et al., 2019. A circulating miRNA signature for early diagnosis of acute kidney injury following acute myocardial infarction. Journal of translational medicine, 17 (1), 139.
   PubMed Web of Science ®Google Scholar
• Freeman, D.J., et al., 2003. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer cell, 3 (2), 117–130.
   PubMed Web of Science ®Google Scholar
• Gan, L., and Zuo, L., 2015. Current ESRD burden and its future trend in Beijing, China. Clinical nephrology, 83 (7 Suppl 1), 17–20.
   PubMedGoogle Scholar
• Han, F., et al., 2015. MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells. Hypertension, 65 (5), 1118–1125.
   PubMed Web of Science ®Google Scholar
• Heegaard, N.H.H., et al., 2012. Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. International journal of cancer, 130 (6), 1378–1386.
   PubMed Web of Science ®Google Scholar
• Huang, D.W., Sherman, B.T., and Lempicki, R.A., 2009a. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research, 37 (1), 1–13.
   PubMed Web of Science ®Google Scholar
• Huang, D.W., Sherman, B.T., and Lempicki, R.A., 2009b. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols, 4 (1), 44–57.
   PubMed Web of Science ®Google Scholar
• Kato, M., et al., 2007. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proceedings of the National Academy of Sciences of the United States of America, 104 (9), 3432–3437.
   PubMed Web of Science ®Google Scholar
• Kato, M., et al., 2009. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nature cell biology, 11 (7), 881–889.
   PubMed Web of Science ®Google Scholar
• Kato, M., et al., 2010. Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells. Journal of biological chemistry, 285 (44), 34004–34015.
   PubMed Web of Science ®Google Scholar
• Kato, M., et al., 2013. TGF-β induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Science Signaling, 6 (278), ra43.
   PubMed Web of Science ®Google Scholar
• Khandelwal, A., et al., 2020. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Cancer science, 111 (3), 826–839.
   PubMed Web of Science ®Google Scholar
• Krupa, A., et al., 2010. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. Journal of the American society of nephrology, 21 (3), 438–447.
   PubMed Web of Science ®Google Scholar
• Lan, H.Y., 2012. Transforming growth factor-β/Smad signalling in diabetic nephropathy. Clinical and experimental pharmacology and physiology, 39 (8), 731–738.
   PubMed Web of Science ®Google Scholar
• Li, J., et al., 2017. miR-217 is a useful diagnostic biomarker and regulates human podocyte cells apoptosis via targeting TNFSF11 in membranous nephropathy. Biomed research international, 2017, 2168767.
   PubMed Web of Science ®Google Scholar
• Li, J.H., et al., 2004. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB journal, 18 (1), 176–178.
   PubMed Web of Science ®Google Scholar
• Liang, M., et al., 2013. Transcriptional cooperation between p53 and NF-κB p65 regulates microRNA-224 transcription in mouse ovarian granulosa cells. Molecular and cellular endocrinology, 370 (1–2), 119–129.
   PubMed Web of Science ®Google Scholar
• Loeffler, I., et al., 2011. Type VIII collagen modulates TGF-β1-induced proliferation of mesangial cells. Journal of the American society of nephrology, 22 (4), 649–663.
   PubMed Web of Science ®Google Scholar
• Ma, X., et al., 2016. The expression of miR-192 and its significance in diabetic nephropathy patients with different urine albumin creatinine ratio. Journal of diabetes research, 2016, 1–6.
   Web of Science ®Google Scholar
• McClelland, A.D., et al., 2015. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. Clinical science, 129 (12), 1237–1249.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence, 2014. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. London: National Institute for Health and Care Excellence: Clinical Guidelines.
   Google Scholar
• Ng, E.K.O., et al., 2009. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58 (10), 1375–1381.
   PubMed Web of Science ®Google Scholar
• Ortega, F.J., Mercader, J.M., et al., 2014. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes care, 37 (5), 1375–1383
   PubMed Web of Science ®Google Scholar
• Pezzolesi, M.G., et al., 2015. Circulating TGF-β1-regulated miRNAs and the risk of rapid progression to ESRD in type 1 diabetes. Diabetes, 64 (9), 3285–3293.
   PubMed Web of Science ®Google Scholar
• Putta, S., et al., 2012. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. Journal of the American society of nephrology, 23 (3), 458–469.
   PubMed Web of Science ®Google Scholar
• Roberts, A.B., and Derynck, R., 2001. Meeting report: signaling schemes for TGF-beta. Science's signal transduction knowledge environment, 2001 (113), pe43.
   PubMedGoogle Scholar
• Rudnicki, M., et al., 2015. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy. Nephrology, dialysis, transplantation, 30 (Suppl 4), iv35–iv42.
   PubMedGoogle Scholar
• Shao, Y., et al., 2017. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine, 55 (1), 130–138.
   PubMed Web of Science ®Google Scholar
• Simpson, K., et al., 2016. MicroRNAs in diabetic nephropathy: from biomarkers to therapy. Current diabetes reports, 16 (3), 35.
   PubMed Web of Science ®Google Scholar
• Stevens, P.E., and Levin, A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members, 2013. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of internal medicine, 158 (11), 825–830.
   PubMed Web of Science ®Google Scholar
• Sun, J., et al., 2017. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway. Biochemical and biophysical research communications, 483 (1), 318–324.
   PubMed Web of Science ®Google Scholar
• Szeto, C.-C., 2014. Urine miRNA in nephrotic syndrome. Clinica Chimica Acta, 436, 308–313.
   PubMed Web of Science ®Google Scholar
• Szeto, C.-C., et al., 2012. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Disease markers, 33 (3), 137–144.
   PubMed Web of Science ®Google Scholar
• Szklarczyk, D., et al., 2019. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic acids research, 47 (D1), D607–D613.
   PubMed Web of Science ®Google Scholar
• Tyack, P.L., et al., 2015. Formal comment on Schorr GS, Falcone EA, Moretti DJ, Andrews RD (2014) first long-term behavioral records from Cuvier's Beaked Whales (Ziphius cavirostris) reveal record-breaking dives. PLOS One., 10 (12), e92633.
   Web of Science ®Google Scholar
• Wang, Y-c., et al., 2013. Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity. Diabetologia, 56 (10), 2275–2285.
   PubMed Web of Science ®Google Scholar
• Wu, X., et al., 1998. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proceedings of the National Academy of Sciences of the United States of America, 95 (26), 15587–15591.
   PubMed Web of Science ®Google Scholar
• Yao, G., et al., 2010. MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Molecular Endocrinology, 24 (3), 540–551.
   PubMedGoogle Scholar
• Yu, S., et al., 2019. The alcohol extract of Coreopsis tinctoria Nutt ameliorates diabetes and diabetic nephropathy in db/db mice through miR-192/miR-200b and PTEN/AKT and ZEB2/ECM pathways. BioMed research international, 2019, 5280514.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2014. The regulation of TGF-β/SMAD signaling by protein deubiquitination. Protein cell, 5 (7), 503–517.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2016. Trends in chronic kidney disease in China. The New England journal of medicine, 375 (9), 905–906.
   PubMed Web of Science ®Google Scholar
• Zununi Vahed, S., et al., 2017. Circulating miR-150, miR-192, miR-200b, and miR-423-3p as non-invasive biomarkers of chronic allograft dysfunction. Archives of Medical Research, 48 (1), 96–104.
   PubMed Web of Science ®Google Scholar